Sign Up to like & get
recommendations!
0
Published in 2017 at "European Journal of Clinical Pharmacology"
DOI: 10.1007/s00228-017-2302-7
Abstract: PurposeTolvaptan (TLV) is indicated to treat hyponatremia due to syndrome of inappropriate diuretic hormone (SIADH) in Europe. Treatment is to be initiated at 15 mg QD but post-approval reporting indicates increasing use of 7.5 mg as the…
read more here.
Keywords:
serum sodium;
healthy adults;
due syndrome;
syndrome inappropriate ... See more keywords